EMCURE PHARMACEUTICALS LIMITED

IPO Details

Emcure Pharma IPO is open for subscription starting Wednesday, July 3, 2024, and closing on Friday, July 5, 2024. The price is decided at Rs 960 to Rs 1008 per share. The minimum lot size for the retail category is 14 shares. The minimum lot size for small NII is 15 lots consisting of 210 shares. Meanwhile, the minimum lot for big non-institutional investors is 71 lots with 994 shares. The minimum investment required for retail category investors is Rs 14,112 (1008 x 14 shares). However, for small non-institutional investors, the minimum investment amount required is Rs 2,11,680 (1008 x 210 shares); for big non-institutional investors, it is Rs 10,01,952 (1008 x 994 shares). Emcure Pharma IPO is a book-built issue of Rs 1952.03 crores. This issue is a combination of fresh issue and offer-for-sale. The fresh issue is of 0.79 crore equity shares amounting to Rs 800 crores and OFS is of 1.14 crore equity shares amounting to Rs 1,152.03 crores. The allotment for this IPO is expected to be finalised on Monday, July 8, 2024. Emcure Pharma Limited IPO will be listed on both BSE and NSE, and the listing date is fixed on Wednesday, July 10, 2024. The book-running lead managers of Emcure Pharma Limited are Kotak Mahindra Capital Company Ltd, Axis Capital Ltd, J.P. Morgan India Private Ltd and Jefferies India Private Limited. The registrar for this new IPO is Link Intime India Private Limited.